Weigh the Benefits and Risks of Vyvanse in Binge-Eating Patients

December 2016

Vyvanse (lisdexamfetamine) is now approved for moderate to severe binge eating disorder in adults...not just for ADHD.

About 1 in 70 adults have a binge eating disorder. These patients have frequent episodes of compulsive, out-of-control overeating...that often lead to obesity and mood disorders.

When suggesting a treatment, consider availability, cost, patient preference, and other comorbid conditions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Infectious Diseases Know When to Hold Off on Antibiotics for Acute Otitis Media
Eating Disorders Weigh the Benefits and Risks of Vyvanse in Binge-Eating Patients
Diabetes Don't Recommend Non-Insulin Diabetes Meds for Most Type 1 Patients
Gout Consider Recommending a Corticosteroid Instead of an NSAID for Acute Gout
Cancer Opioids Are Still Appropriate for Moderate or Severe Cancer Pain
Women's Health Help Women Use the Right Approach for Breastfeeding Problems
Vaccines Recommend Rotavirus Vaccine for All Infants
Vaccines Explain Why Patients Shouldn't Wait to Get Shingrix Instead of Zostavax II
Neurology & Pain Counsel Patients to Report Signs of Respiratory Depression With Gabapentin
Pregnancy Expect to See LMWH in Pregnant Women at Risk for Thromboembolism
Natural Health Products Tell Patients Not to Rely on Turmeric
Medication Errors Avoid Mix-Ups With Trajenta, Trulicity, and Toujeo

Weigh the Benefits and Risks of Vyvanse in Binge-Eating Patients

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents